Because GLP-1 medications completely rewire hunger and fullness cues, theres also concern about getting proper nutrition while taking them
India is a significant contributor to the market as there is a big and growing number of diabetics, increased awareness of weight management, and access to cheaper generic and biosimilar versions of these drugs
This introduces the tentative proposition that Ipamorelin might not just enhance gastric muscle contractility, but also possibly counterbalance the repressive outcomes instigated by specific surgical measures
Other medications like Kerendia (finerenone) that do not lower glucose are sometimes included as adjunctive therapies, too
Celia has been amazing in helping me understand exactly what all I
But as this study notes, there may be trade-offs when using them alongside GLP-1based therapies